P. Cox

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

H. H. Jensen, P. Wilding, S. Pocock, 2017, The Lancet.

Clopidogrel resistance in stroke patients (The CRISP Trial)

J. Thachil, Sumbal Zaidi, E. Qazi, 2014, Journal of Neurology & Stroke.

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, Johshua N. Fletcher, 2019, The Lancet. Neurology.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, M. Dennis, 2019, Lancet.

Effects of fluoxetine on functional outcomes after acute stroke ( FOCUS ) : a pragmatic , double blind , randomised , controlled

Joshua R. Smith, Ashutosh Kumar Singh, Stephen H. Levy, 2019 .

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

C. Sudlow, P. Sandercock, D. Werring, 2018, Trials.